Boston Scientific has added Obsidio’s novel GEM technology to the BSC IO #embolization portfolio. This unique technology is the only semi-solid cleared by the FDA for embolization in the peripheral vasculature. #RelentlessPursuit #irad Learn more: https://lnkd.in/gBwAhhRm
Great news. Many congratulations Peter Pattison…
Congratulations Peter!
Learn more about the #FRONTIERstudy: https://bit.ly/3UifcLi #recurrentGBM #TheraSphereGBM #Y90 Caution: Investigational Device. Limited by Federal (or US) law to investigational use only. Not available for sale. TheraSphere is not indicated for GBM, and is being studied for such in the FRONTIER clinical trial.
Go Behind The Bench of Lenox Hill Neurosurgery’s FRONTIER clinical trial, sponsored by Boston Scientific Peripheral Interventions. 🔬🧬 The aim of this study is to assess the safety and feasibility of the intra-arterial delivery of TheraSphere™ GBM Y-90 Glass Microspheres in patients with recurrent glioblastoma. Lenox Hill Hospital’s Chief of Neuroendovascular Surgery, Dr. Yafell Serulle, MD, PhD, Interventional Radiologist, Dr. Jonathan Weinstein, and Senior Clinical Research Project Manager, Sanskruti (Sana) Bokil, BS, MS, share how they combine their respective expertise to facilitate this trial and the importance of offering patients treatment at every stage of this disease. Click the link for more information about the FRONTIER study or to contact our Clinical Research Team about enrolling in one of our clinical trials. 🧠 Caution: Investigational Device. Limited by Federal (or US) law to investigational use only. Not available for sale. TheraSphere is not indicated for GBM, and is being studied for such in the FRONTIER clinical trial. https://lnkd.in/eU_uvUB4 #lenoxhillneurosurgery #lenoxhillhospital #lenoxhill #northwellhealth #northwelllife #northwellcancerinstitute #bostonscientific #glioblastomaawarenessday #glioblastomaawareness #glioblastomaresearch #braintumorresearch #braincancerresearch #neurosurgery #neurosurgeon #madeforthis #raisinghealth #igreels #instagramreels #reels #fyp
#Fellows, join us in Austin, TX to hear from a panel of world-class faculty as they give an in-depth educational experience on key interventional tools and techniques through case-based didactic presentations and hands-on training. Register now: https://cvent.me/DgkyER #MedEd
Thrilled to announce our first site activation & patient treated in the #OCCLUDEregsitry, a prospective, multi-center registry assessing the effectiveness & safety outcomes of #Obsidio #ConformableEmbolic. Huge thanks Dr. Christopher Grilli and the dedicated team ChristianaCare for making it happen. Want to see more Obsidio data? Check out the data page on our site to learn more: https://bit.ly/4bEGJMt
#TheraSphereGBM #FRONTIERstudy Caution: Investigational Device. Limited by Federal (or US) law to investigational use only. Not available for sale. TheraSphere is not indicated for GBM, and is being studied for such in the FRONTIER clinical trial
Retired US Navy Admiral Danelle Barrett is one of fewer than 200 women in history to achieve that rank. But now, decades after serving tours in Iraq and Afghanistan and as the Director of Navy Cybersecurity, Danelle is battling glioblastoma. Mr. G from PIX11 sat down with Danelle for a conversation about her treatment at Lenox Hill Hospital under the care of Dr. John Boockvar. Danelle shares how she is approaching her treatment with the same determination as she did during her tenure in the Navy and how she is hopeful that participating in one of our clinical trials will help her to defy the statistics for patients diagnosed with this disease. ❤️🇺🇸 https://lnkd.in/e54DrTZZ #lenoxhillneurosurgery #lenoxhillhospital #lenoxhill #northwellhealth #northwelllife #pix11news #gthing #glioblastomawarrior #glioblastomaresearch #clinicalresearch #clinicaltrials #braincancerresearch #madeforthis #raisinghealth
Thrilled to introduce the #OCCLUDEregistry, a multi-center registry assessing the effectiveness & safety outcomes of #Obsidio #ConformableEmbolic. This would not be possible without lead PI Rahul Patel Mount Sinai Health System thank you for all of the hard work! Learn more about additional #Obsidio data here: https://bit.ly/4cO6yuz
New JVIR #Obsidio #ConformableEmbolic Publication! This single-center retrospective study evaluated outcomes following embolization using Obsidio. Read the full publication here: https://bit.ly/4bq0uqM JVIR Media Safety: https://bit.ly/3wnXYCT
Ready to learn more about #Obsidio #ConformableEmbolic? Join us July 27th for an in-person masterclass with expert faculty Kevin Henseler MD, FACR and Rahmi Oklu MD, PhD, FSIR. Spots are limited - secure yours soon! Register here: https://bit.ly/45EpCsP
Thank you to everyone who attended the Vascular Live! session at #VAM24! Huge shoutout to Anahita Dua, MD, Misty Humphries, MD, and Elizabeth Genovese, MD, MS, FACS, RPVI for bringing their expert perspectives to answering the question “Is leave nothing behind a realistic goal in all SFA lesions?”
Join our esteemed faculty at #VAM2024 as they explore the critical question “Is leave nothing behind a realistic goal in all SFA lesions?”, aiming to provide optimal outcomes tailored to each patient.
Very exciting news! #TCAR is at the forefront of innovation in #vascularmedicine enabling an innovative and clinically differentiated procedure to prevent stroke in patients with carotid artery disease. We look forward to the Silk Road Medical, Inc. team joining BSC and PI! #VascularSurgery
We’re excited to share that we have entered into a definitive agreement to acquire Silk Road Medical, Inc., a med tech company focused on stroke prevention in patients with carotid artery disease through the TCAR procedure. Upon close, we look forward to bringing this innovative and clinically differentiated technology to vascular surgeons and welcoming the Silk Road team to Boston Scientific and Peripheral Interventions! https://bit.ly/3XtVUVh
Professor at University of Macau
1ybravo!